Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
20806-43-3
93204-37-6
3005-66-1
145881-74-9
19645-29-5
206265-31-8
771583-24-5 | (1-(4-Fluorophenyl)cyclohexyl)methanamine HCl | AA00G77U | MFCD06213189
81764-67-2 | 3-Azidooxetane | AA00G7JA | MFCD18839088
771574-32-4 | 4-Bromo-2-chlorobenzylamine | AA00G84R | MFCD06213844
827326-63-6 | N-(3,4-dichlorobenzyl)-2-(pyrrolidin-1-yl)ethanamine | AA00G8Q6 | MFCD04399827
776315-23-2 | 4-Bromo-3-formylbenzoic acid | AA00G9B8 | MFCD20485838
852934-06-6 | (4-Ethylphenyl)(3-fluorophenyl)methylamine | AA00G9K1 | MFCD06655634
79389-41-6 | (1R,2S)-2-Methylcyclohexanamine hydrochloride | AA00G9VI | MFCD22201094
813424-16-7 | 6-Amino-1-methyl-2-oxoindoline | AA00GA7H | MFCD17015857
81591-83-5 | 4,4'-bis(oxiran-2-ylmethyl)-1,1'-biphenyl | AA00GAME | MFCD30490703
780738-23-0 | 7-Bromo-6-methyl-1,2,3,4-tetrahydroisoquinoline | AA00GFBQ | MFCD27957895